@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_head { this: np:hasAssertion dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_assertion; np:hasProvenance dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_provenance; np:hasPublicationInfo dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_publicationInfo; a np:Nanopublication . dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_assertion a np:Assertion . dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_provenance a np:Provenance . dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_publicationInfo a np:PublicationInfo . } dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_assertion { miriam-gene:1958 a ncit:C16612 . lld:C0027819 a ncit:C7057 . dgn-gda:DGN072b95b5e5f0523a4a1b8905367609be sio:SIO_000628 miriam-gene:1958, lld:C0027819; a sio:SIO_001121 . } dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_provenance { dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_assertion dcterms:description "[Our results are summarized as follows: (i) a recombinant HSV (M012) was constructed in which both copies of the gamma(1)34.5 gene were replaced with the bacterial CD gene, under the control of the cellular promoter Egr-1; (ii) M012-infected cells in vitro efficiently convert 5-fluorocytosine (5-FC) to 5-fluorouracil, thereby enhancing cytotoxicity of neighboring, uninfected cells; (iii) both direct and bystander cytotoxicity of murine neuroblastoma and human glioma cell lines after infection with M012 were demonstrated; (iv) direct intracerebral inoculation of A/J mice demonstrated lack of neurotoxicity at doses similar to G207, a gamma(1)34.5-deleted HSV with demonstrated safety in human patient trials and (v) intratumoral injection of M012 into Neuro-2a flank tumors in combination with 5-FC administration significantly reduced tumor growth versus tumors treated with R3659 combined with 5-FC, or treated with M012 alone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:16990846; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP570584.RAuExikQVNVewxMNvIA4rpxv0GRn8LZMJL1PR3fGH0qd8130_publicationInfo { this: dcterms:created "2016-05-13T12:46:03+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }